Researchers report a brain computer interface can enable those with paralysis to directly operate tablet technology just by thinking about cursor movements and clicks.
Researchers have identified the normal function of C9orf72, a gene commonly implicated in ALS and FTD.
Researchers report activating microglia may help reduce the imbalance between neuroprotection and neurotoxicity for neurodegenerative diseases.
A new study provides new clues for the links between aging and neurodegenerative diseases.
A new method reveals some ALS affected neurons display hypo-excitability. Researchers say these changes most likely represent early steps in the disease progression.
Researchers shed light on how stress granules, enzymes linked to a range of neurodegenerative diseases, are formed and how they can be reduced.
Tongue range motion is reduced while lower lip and jaw motion is increased in people who suffer dysarthria associated with ALS. The findings may help develop new therapies to help those with ALS improve their speech, researchers say.
A new collaborative study has helped researchers to uncover some of the earliest molecular events in ALS.
Researchers reveal a small region of Ataxin-2, a protein implicated in long term memory, may drive the progression of ALS.
A new immunotherapy treatment for ALS patients is not only safe, but can also help slow the progression of the disease, researchers report.
Researchers report transplanting altered neural stem cells into the brains of mice genetically engineered to exhibit symptoms of ALS, delayed the progression of the disease and extended lifespan.
Researchers report the formation of larger, more visible SOD1 aggregates may help to protect brain cells.
